arrow
F

Fernando Baquero-Artigao

Hospital Universitario La Paz
H指数:27
被引数:2,482

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

First report of proven Fusarium brachygibbosum sinusitis in a paediatric patient with acute myeloblastic leukaemia

首次报道:急性髓系白血病儿童患者中确诊的短凸顶镰刀菌鼻窦炎

2026-10-130
PRE
Urinary Cytomegalovirus Load at Birth as a Predictor of Sequelae in Congenital Cytomegalovirus Infection

新生儿尿液中巨细胞病毒载量作为先天性巨细胞病毒感染后遗症的预测因子

2026-01-011
PRE
Prognostic Factors of Late-onset Hearing Loss in Infants With Congenital Cytomegalovirus and Normal Audiologic Assessment at Birth

Buonsenso, D.; Pedrero-Tomé, R.; Raimondi, F.; Salomé, S.; Papaevangelou, V.; Syridou, G.; Ríos-Barnés, M.; Fortuny, C.; Villaverde, S.; de Vergas, J.; 等. 先天性巨细胞病毒感染婴儿出生时听力评估正常者晚期听力损失预后因素. Pediatr. Infect. Dis. J. 2026, 45, 1–10. [Google Scholar] [CrossRef] [PubMed]

2026-01-013
PRE
Severe Neutropenia in Infants With Congenital Cytomegalovirus on Antiviral Therapy
2025-11-010
PRE
Early Nirsevimab Administration During Hospitalization for RSV Bronchiolitis may Reduce Disease Severity in Non-immunized infants: A Descriptive Study

住院期间早期给予Nirsevimab治疗RSV毛细支气管炎可能减轻未免疫婴儿的疾病严重程度:一项描述性研究

2025-07-010
PRE
Clinical presentation, diagnostics, and outcomes of infants with congenital and postnatal tuberculosis: a multicentre cohort study of the Paediatric Tuberculosis Network European Trials Group (ptbnet)

先天性及产后结核病患儿的临床表现、诊断及预后:Paediatric Tuberculosis Network European Trials Group (ptbnet) 多中心队列研究

2025-06-010
PRE
T-Cell Immune Responses in Newborns and Long-Term Sequelae in Congenital Cytomegalovirus Infection (CYTRIC Study)
2024-09-014
PRE
Pseudomonas aeruginosa bloodstream infections in children and adolescents: risk factors associated with carbapenem resistance and mortality

儿童和青少年铜绿假单胞菌血流感染: 与碳青霉烯类耐药和死亡率相关的危险因素

2024-07-010
PRE
QuantiFERON-TB reversion in children and adolescents with tuberculosis

儿童和青少年结核病的定量结核逆转

2024-03-210
OAAI
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial

ChAd155载体呼吸道合胞病毒疫苗在6-7个月婴儿中的安全性和免疫原性: 1/2期随机试验

2023-07-214
OAAI
Epidemiology and clinical features of Streptococcus pyogenes bloodstream infections in children in Madrid, Spain
2023-05-0414
OA
Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age

在6个月以下的婴儿中,每天10 mg/kg的抗结核药物异烟肼的剂量是否足够

2023-01-300
OA
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age

ChAd155载体呼吸道合胞病毒 (RSV) 疫苗在12-23个月健康RSV血清阳性儿童中的安全性和免疫原性

2022-12-0916
OAAI
Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain
2022-11-0511
OAAI
Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study
THORAX
IF7.7
2022-10-2514
OA
Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study
THORAX
IF7.7
2022-09-016
PRE